scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.1998.16.4.1594 |
P953 | full work available at URL | http://intl.jco.org/cgi/content/abstract/16/4/1594 |
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.4.1594 | ||
P698 | PubMed publication ID | 9552071 |
P2093 | author name string | S. Edgerton | |
D. E. Theobald | |||
M. V. McDonald | |||
B. Rosenfeld | |||
W. Dugan | |||
S. D. Passik | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
P304 | page(s) | 1594-1600 | |
P577 | publication date | 1998-04-01 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Oncologists' recognition of depression in their patients with cancer | |
P478 | volume | 16 |
Q73974765 | "I'm sorry to tell you ..." physicians' reports of breaking bad news |
Q33729034 | "What concerns me is..." Expression of emotion by advanced cancer patients during outpatient visits |
Q33981845 | A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). |
Q35801735 | A brief symptom index for advanced lung cancer |
Q89957403 | A qualitative approach in determining the patient-centered information and supportive care needs of cancer patients in Singapore |
Q49256878 | A simple filter model to guide the allocation of healthcare resources for improving the treatment of depression among cancer patients |
Q73634547 | A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population |
Q44839381 | Adolescent survivors of childhood cancer: are they vulnerable for psychological distress? |
Q37738177 | Advances in quality of life research among head and neck cancer patients |
Q35862164 | Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer |
Q36626916 | An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder |
Q52065319 | An attempt to employ the Zung Self-Rating Depression Scale as a "lab test" to trigger follow-up in ambulatory oncology clinics: criterion validity and detection |
Q48506093 | An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients |
Q55266062 | Analysis of psychosocial stress factors in patients with renal cancer. |
Q47946477 | Antidepressant prescribing in community cancer care |
Q36718619 | Antidepressant use in ambulatory cancer patients |
Q81156895 | Anxiety and the blues after breast cancer: how common are they? |
Q33759223 | Anxiety disorders in advanced cancer patients: correlates and predictors of end-of-life outcomes |
Q53500690 | Are healthcare providers adequate raters of patients' quality of life--perhaps more than we think? |
Q35910445 | Assessment of depression severity with the PHQ-9 in cancer patients and in the general population |
Q51044661 | Assessment of psychological distress in prospective bone marrow transplant patients |
Q33841133 | Assessment of the older cancer patient |
Q91950059 | Association between depression and healthcare expenditures among elderly cancer patients |
Q46077129 | Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial |
Q46915278 | Associations between Plasma Cytokines and Depressive Mood in Patients with Breast Cancer |
Q50532563 | Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms |
Q40709856 | Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients |
Q37119191 | Breast cancer follow-up in the adjuvant setting |
Q30661280 | Cancer distress screening data: translating knowledge into clinical action for a quality response |
Q45209908 | Cancer patients' reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: a preliminary study. |
Q36609609 | Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience |
Q33583900 | Characteristics of attempted suicide by patients with schizophrenia compared with those with mood disorders: a case-controlled study in northern Japan |
Q33558690 | Childhood adversity and herpesvirus latency in breast cancer survivors |
Q40311680 | Chronic therapy with selective serotonin reuptake inhibitors and survival in newly diagnosed cancer patients |
Q46587232 | Clinic-based depression screening in lung cancer patients using the PHQ-2 and PHQ-9 depression questionnaires: a pilot study |
Q51113807 | Clinical experience of the modified nurse-assisted screening and psychiatric referral program |
Q48217561 | Clinical indicators of depression among ambulatory cancer patients undergoing chemotherapy |
Q36440120 | Clinical practice guidelines for the management of psychosocial distress at the end of life |
Q47918708 | Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints |
Q88560402 | Computer-based monitoring and evaluation of epilepsy-related health variables and their impact on treatment decision |
Q37352665 | Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology |
Q46273620 | Correlates of depressive symptoms among women seeking cancer genetic counseling and risk assessment at a high-risk cancer clinic |
Q40823331 | Correlates of oncologist-issued referrals for psycho-oncology services: what we learned from the electronic voluntary screening and referral system for depression (eVSRS-D). |
Q45953908 | Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients |
Q47347512 | Criterion validation of the Edinburgh postnatal depression scale as a screening tool for depression in patients with advanced metastatic cancer |
Q39471599 | Depressed patients with incurable cancer: which depressive symptoms do they experience? |
Q36622795 | Depression Treatment in Individuals with Cancer: A Comparative Analysis with Cardio-Metabolic Conditions |
Q34642766 | Depression and barriers to mental health care in older cancer patients |
Q35237260 | Depression and end-of-life care for patients with cancer |
Q45325033 | Depression assessment by oncologists and palliative care physicians |
Q35634135 | Depression in cancer patients: a critical review |
Q44321759 | Depression is associated with some patient-perceived cosmetic changes, but not with radiotherapy-induced late toxicity, in long-term breast cancer survivors |
Q37029143 | Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. |
Q80439335 | Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome |
Q34605151 | Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer |
Q30238703 | Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. |
Q79335050 | Depressive symptoms during and after radiotherapy for head and neck cancer |
Q44415376 | Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional |
Q81403035 | Descriptive analysis of clinical factors affecting terminally ill cancer patients |
Q53046021 | Development and Validation of 11 Symptom Indexes to Evaluate Response to Chemotherapy for Advanced Cancer |
Q57653189 | Development and validation of eleven symptom indexes to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands |
Q51948926 | Development of a brief screening interview for adjustment disorders and major depression in patients with cancer |
Q48315237 | Development of guidelines for distress management in Korean cancer patients |
Q49055973 | Diagnosis and treatment of depression in patients with advanced illness |
Q44037250 | Distress and quality of life in primary high-grade brain tumor patients. |
Q35762243 | Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress |
Q34135620 | Do claimants over-report behavioral health dysfunction when filing for work disability benefits? |
Q36034212 | Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches? |
Q57031058 | Doctor's recommendations for psychosocial care: Frequency and predictors of recommendations and referrals |
Q40682504 | Drug interactions between antineoplastic and antidepressant agents: analysis of patients seen at an oncology clinic at a general hospital |
Q35354379 | Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks |
Q51902857 | Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial |
Q33807805 | Effect of sex and gender on psychosocial aspects of prostate and breast cancer |
Q34440359 | Effect of telecare management on pain and depression in patients with cancer: a randomized trial |
Q36453878 | Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians. |
Q38936349 | Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer. |
Q47574538 | Empathy and the failure to treat pain |
Q58283102 | Euthanasia and physician-assisted suicide |
Q36231171 | Euthanasia: An Indian perspective |
Q34730661 | Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany |
Q81841950 | Factors that influence physicians' detection of distress in patients with cancer: can a communication skills training program improve physicians' detection? |
Q42772667 | Fatigue in cancer |
Q44438545 | Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology Group |
Q42963369 | Follow-up after breast cancer |
Q48727139 | Frequency of depression among oncology outpatients and association with other symptoms |
Q89890239 | Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes |
Q48900441 | Hematology/oncology fellows' training in palliative care: results of a national survey |
Q36622443 | How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? |
Q49035618 | Identifying tumor patients' depression |
Q92400330 | Impact of Onset of Psychiatric Disorders and Psychiatric Treatment on Mortality Among Patients with Cancer |
Q39376991 | Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors |
Q39342839 | Impact of surgical wound dehiscence on health-related quality of life and mental health. |
Q36470419 | Implementing evidence-based psychological treatments for cancer patients |
Q47879981 | Implications of a needs assessment intervention for people with progressive cancer: impact on clinical assessment, response and service utilisation |
Q37390123 | Improving primary care for older adults with cancer and depression |
Q35569155 | Improving the psychological care of cancer patients and their relatives. The role of specialist nurses |
Q35792639 | Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. |
Q58288989 | Information exchange in oncology outpatient clinics: source, valence and uncertainty |
Q35624527 | Insulin and cancer |
Q38672371 | Integrating Psychosocial Care Into Routine Cancer Care. |
Q46511856 | Integrating mental health screening and abnormal cancer screening follow-up: an intervention to reach low-income women |
Q24202217 | Interventions to improve continuity of care in the follow-up of patients with cancer |
Q24240264 | Interventions to improve continuity of care in the follow-up of patients with cancer |
Q53500694 | Is 'bedside medicine' returning to oncology? |
Q35073461 | Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer? |
Q92446638 | Liaison psychiatry in a central nervous system tumor service |
Q33816624 | Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment |
Q36514293 | Longitudinal comparison of three depression measures in adult cancer patients. |
Q38027186 | Measurement of Health‐Related Quality of Life in the Care of Patients with ESRD: Isn’t This the Metric That Matters? |
Q48941889 | Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer |
Q46258198 | Mental adjustment to cancer: the role of anxious and depressive symptoms under treatment |
Q37823816 | Novel Approaches to Perioperative Assessment and Intervention May Improve Long-Term Outcomes After Colorectal Cancer Resection in Older Adults |
Q48608072 | Nurses' recognition of the mental state of cancer patients and their own stress management ― a study of Japanese cancer‐care nurses |
Q48069915 | On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer |
Q35176995 | Oncologists' perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates |
Q36010668 | Oncologists’ assessments of lung cancer patient and family disagreements regarding treatment decision making |
Q37203645 | Oncology outpatient and provider responses to a computerized symptom assessment system |
Q52167333 | Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program |
Q34363581 | Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting. |
Q90217965 | Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System |
Q30331774 | Palliative care provision and its impact on psychological morbidity in cancer patients. |
Q97531650 | Parallel Journeys of Patients with Cancer and Depression: Challenges and Opportunities for Technology-Enabled Collaborative Care |
Q85183757 | Patient Benefits From Psychosocial Care: Screening for Distress and Models of Care |
Q33884399 | Patient and staff perceptions of cancer patients' psychological concerns and needs |
Q37249363 | Patient-physician communication about health-related quality-of-life problems: are non-Hodgkin lymphoma survivors willing to talk? |
Q77105497 | Patients’ Perceptions of Receiving Bad News About Cancer |
Q50639207 | Patients’ negative emotional cues and concerns in hospital consultations: A video-based observational study |
Q34696378 | Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors |
Q50085733 | Performance of four diagnostic approaches to depression in adults with cancer. |
Q47344748 | Performance status 1 predicts psychological response in female, but not male, ambulatory cancer patients |
Q33247628 | Physician-assisted suicide: a review of the literature concerning practical and clinical implications for UK doctors |
Q73589038 | Predicting anxiety and depression among cancer patients: a clinical model |
Q74715777 | Predictive factors for suicidal ideation in patients with unresectable lung carcinoma |
Q46874972 | Prevalence of Abnormal Echocardiographic Findings in Cancer Patients: A Retrospective Evaluation of Echocardiography for Identifying Cardiac Abnormalities in Cancer Patients |
Q50755245 | Prevalence of depression among cancer patients in Jordan: a national survey |
Q43419174 | Prevalence of depression among relatives of cancer patients in Jordan: a cross-sectional survey |
Q34848420 | Prevalence of depression and anxiety in patients requesting physicians' aid in dying: cross sectional survey |
Q34806874 | Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments |
Q46324032 | Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies |
Q33768621 | Prevalence of emotional symptoms in Chilean oncology patients before the start of chemotherapy: potential of the distress thermometer as an ultra-brief screening instrument |
Q51976408 | Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer |
Q36791086 | Primary extraosseous Ewing sarcoma of the lung in children |
Q48494151 | Priority Symptoms in Advanced Breast Cancer: Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16) |
Q43824293 | Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma |
Q34599819 | Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study |
Q36936909 | Psychiatric disorders in advanced cancer |
Q36622912 | Psychiatric morbidity and its recognition by doctors in patients with cancer |
Q37962252 | Psycho-Oncology: Structure and Profiles of European Centers Treating Patients With Gynecological Cancer |
Q36989817 | Psychological Status and Associated Factors among Korean Cancer Survivors: a Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys |
Q35875041 | Psychological health in cancer survivors |
Q37203840 | Psychological intervention reduces postembolization pain during hepatic arterial chemoembolization therapy: a complementary approach to drug analgesia |
Q40988835 | Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship |
Q79805988 | Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation |
Q60621970 | Psychosocial problems secondary to cancer |
Q48588526 | Psychosocial supportive care for children receiving stem cell transplantation: practice patterns across centers |
Q33274849 | Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy. |
Q35099020 | Quality of life information and trust in physicians among families of children with life-limiting conditions |
Q33837258 | Quality of life instruments in oncology |
Q39704040 | Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study |
Q37121640 | Randomized controlled trial of collaborative care management of depression among low-income patients with cancer |
Q36695588 | Rapid screening for depression--validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients |
Q90382930 | Rational Suicide in Late Life: A Systematic Review of the Literature |
Q36868626 | Receipt of Psychosocial Care Among Cancer Survivors in the United States |
Q24671683 | Recognition of depression by non-psychiatric physicians--a systematic literature review and meta-analysis |
Q38209521 | Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force |
Q47283829 | Relationship between physicians' perceived stigma toward depression and physician referral to psycho-oncology services on an oncology/hematology ward. |
Q36095796 | Review and critique of the quality of exercise recommendations for cancer patients and survivors |
Q44316133 | Routine screening for psychological distress on an Australian inpatient haematology and oncology ward: impact on use of psychosocial services |
Q50988694 | Routine screening for psychosocial distress following hematopoietic stem cell transplantation |
Q39769469 | Screening for distress and supportive care needs during the initial phase of the care process: a qualitative description of a clinical pilot experiment in a French cancer center |
Q34432415 | Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age |
Q35820240 | Screening for emotional distress in cancer patients: a systematic review of assessment instruments |
Q50977718 | Screening for psychologic distress in ambulatory cancer patients |
Q34467192 | Screening for psychological distress in patients with lung cancer: results of a clinical audit evaluating the use of the patient Distress Thermometer |
Q51701181 | Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer |
Q92726816 | Serious illness care Programme UK: assessing the 'face validity', applicability and relevance of the serious illness conversation guide for use within the UK health care setting |
Q44119419 | Standardized geriatric assessment or comprehensive gerontological assessment: where do we stand? |
Q37513262 | Stress generation over the course of breast cancer survivorship |
Q35599063 | Studies of comprehensive geriatric assessment in patients with cancer |
Q48873235 | Suicide in women with gynecologic cancer |
Q48188176 | Symptoms overlooked in hospitalized cancer patients: Impact of concurrent symptoms on overlooked by nurses |
Q50920236 | Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study |
Q30327168 | The 'right kind' of pain: talking about symptoms in outpatient oncology consultations. |
Q35629577 | The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients |
Q34590031 | The Distress Thermometer and Its Validity: A First Psychometric Study in Indonesian Women with Breast Cancer |
Q47952282 | The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up |
Q37346617 | The Indiana Cancer Pain and Depression (INCPAD) trial Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants |
Q33978339 | The James Supportive Care Screening: integrating science and practice to meet the NCCN guidelines for distress management at a Comprehensive Cancer Center |
Q37796537 | The Oncologist's Role in Delivering Palliative Care |
Q37796549 | The Oncologist's Role in Managing Depression, Anxiety, and Demoralization With Advanced Cancer |
Q34107655 | The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients |
Q31029367 | The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East England |
Q39462416 | The cancer psychosocial care matrix: a community‐derived evaluative tool for designing quality psychosocial cancer care delivery |
Q40721909 | The changeable nature of patients' fears regarding chemotherapy: implications for palliative care |
Q33464696 | The effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in cancer patients treated with radiotherapy: design of a cluster randomised controlled trial |
Q36390235 | The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review |
Q58590756 | The global burden of multiple chronic conditions: A narrative review |
Q34009204 | The importance of quality-of-life endpoints in clinical trials to the practicing oncologist |
Q82810555 | The measure of psychological distress in cancer patients: the use of Distress Thermometer in the Oncological Rehabilitation Center of Florence |
Q48627293 | The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer |
Q35805736 | The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures |
Q37305210 | The role of primary care physicians in cancer care |
Q48716661 | The role of trait emotional intelligence in the diagnostic cancer pathway |
Q34070144 | The usefulness and feasibility of a screening instrument to identify psychosocial problems in patients receiving curative radiotherapy: a process evaluation. |
Q46204642 | Tobacco use among long-term survivors of head and neck cancer treated with radiation therapy |
Q34095808 | Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication |
Q40493557 | Treatment of depression in cancer and non-cancer patients in German neuropsychiatric practices |
Q35600438 | Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication |
Q35584773 | Tumor Epidermal Growth Factor Receptor Genotype and Depression in Stage IV Non-Small Cell Lung Cancer |
Q61444891 | Twelve Chinese herbal preparations for the treatment of depression or depressive symptoms in cancer patients: a systematic review and meta-analysis of randomized controlled trials |
Q39937311 | Unmet supportive needs of cancer patients in an acute care hospital in Japan--a census study |
Q44233595 | Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project |
Q52551121 | Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation |
Q48895468 | Usefulness of pharmacist‐assisted screening and psychiatric referral program for outpatients with cancer undergoing chemotherapy |
Q81528873 | Usefulness of the nurse-assisted screening and psychiatric referral program |
Q36654637 | Validation and reliability of distress thermometer in Chinese cancer patients |
Q47383248 | Validation of the distress and impact thermometer and the changes of mood during the first 6 months of treatment in gynecological cancer patients: a Kansai Clinical Oncology Group (KCOG)-G1103 prospective study. |
Q46965723 | Validation of the emotion thermometers and hospital anxiety and depression scales in Singapore: Screening cancer patients for distress, anxiety and depression |
Q44247043 | Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients. |
Q47618017 | What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital |
Q36135211 | Who Provides Psychosocial Follow-Up Care for Post-Treatment Cancer Survivors? A Survey of Medical Oncologists and Primary Care Physicians |
Q45788530 | Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer |
Search more.